TREATMENT OF COGNITIVE IMPAIRMENT WITH COMBINATION THERAPY
申请人:Universiteit Maastricht
公开号:EP3033077A1
公开(公告)日:2016-06-22
Treatment of Cognitive Impairment with Combination Therapy
申请人:Takeda GmbH
公开号:US20150051246A1
公开(公告)日:2015-02-19
Treatment of varying degrees of cognitive impairment associated with Alzheimer's disease with a combination of a phosphodiesterase 4 inhibitor and an acetylcholinestase inhibitor, including roflumilast and donepezil hydrochloride.
US8501779B2
申请人:——
公开号:US8501779B2
公开(公告)日:2013-08-06
[EN] TREATMENT OF COGNITIVE IMPAIRMENT WITH COMBINATION THERAPY<br/>[FR] TRAITEMENT D'UNE DÉFICIENCE COGNITIVE À L'AIDE D'UNE POLYTHÉRAPIE
申请人:TAKEDA GMBH
公开号:WO2015022417A1
公开(公告)日:2015-02-19
Treatment of varying degrees of cognitive impairment associated with Alzheimer's disease with a combination of a phosphodiesterase 4 inhibitor and an acetylcholinesterase inhibitor, including roflumilast and donepezil hydrochloride.